InnoCare Pharma Limited
HKEX:9969.HK
Overview | Financials
Company Name | InnoCare Pharma Limited |
Symbol | 9969.HK |
Currency | HKD |
Price | 5.8 |
Market Cap | 8,687,994,000 |
Dividend Yield | 0% |
52-week-range | 4.03 - 7.49 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jisong Cui Ph.D. |
Website | https://www.innocarepharma.com |
An error occurred while fetching data.
About InnoCare Pharma Limited
InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD